A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is R$ 507,44, with a 24-hour trading volume of R$ 1,86B. The asset's market cap is R$ 1,57T, after moving 1.26% in the last day.
Tokenized AstraZeneca PLC is trading at R$ 508,41, with a tokenized market cap of R$ 3,81M and a 24-hour trading volume of R$ 362,14K. The tokenized asset has moved 1.01% in the past 24 hours.